Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment

NCT00632255 · clinicaltrials.gov ↗

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia
Newly Diagnosed

Interventions

DRUG: Imatinib

Sponsor

Imperial College London

Collaborators

[object Object]